namilumab alternative identifier human monoclonal antibody class kappa targets granulocyte macrophagecolony stimulating factor gmcsfcolony stimulating factor currently researched application rheumatoid arthritis ra psoriatic clinical trials investigating therapeutic utility namilumab include phase phase ii clinical trials establish safety tolerability preliminary therapeutic utility antibody plaque rheumatoid namilumab produced micromet inc development takeda pharmaceuticals immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikinamilumab